Closed
Exercise
Calculated transaction value
$0

Paolini John F. Chief Medical Officer

Transaction date Nov 2, 2026
Public filing date Nov 3, 2026
Filing lag Filed 1 day later

KNSA daily price context

Close on/before transaction
$90.8 Nov 2, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Share Option on Class A Ordinary Share
Quantity / price
6,455 shares @ $0
SEC ownership
Direct
Transaction code
M
Form
4
Filing identifier
0001741533-26-000012
Filing cohort

Transactions in this filing

Showing 15 of 18
Trades
18
Issuers
1
Estimated value
$11.24M
Buys / sales
0 / 10
Transactions reported in the same official filing
Issuer Transaction Traded Value
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 2, 2026 $83.04K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $199.65K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $214.29K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 2, 2026 $1.57M
Kiniksa Pharmaceuticals International, Plc KNSA Current Exercise Nov 2, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 2, 2026 $66.24K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $699.63K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $383.88K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $3.85M
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $1.19M
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $210.69K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $642.44K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $0